Does a peptide really boost testosterone? Here's what the research says

What did @maxradovanic actually say?

The creator claims that a peptide called Testigen "actually does boost your testosterone levels" and that it can help with male infertility, sperm count, libido, erectile dysfunction, and fatigue caused by hormonal imbalance. They describe it as derived from animal testes, originally producing a natural compound called Testilutin, which was then synthesized into the faster-acting Testigen during Cold War-era Soviet research.

They also draw a clear distinction from exogenous testosterone therapy, saying Testigen "does not introduce external hormones in your body" but instead "helps regulate and restore your body's natural hormone function." The video closes with a direct sales pitch for Mile High Compounds, where Testigen is now in stock.

That framing, restoration rather than replacement, is doing a lot of work here. Let's see if the science holds it up.

Does the science back this up?

Partially, but with serious caveats. The honest answer is that the human evidence for Testigen is thin, and most of what exists comes from Russian-language literature that has not been independently replicated in large, peer-reviewed Western trials.

Bioregulators as a class, short peptide chains designed to modulate specific tissue function, were developed extensively by Vladimir Khavinson and colleagues at the St. Petersburg Institute of Bioregulation and Gerontology beginning in the 1970s. Khavinson's group has published extensively on cytomedins and synthetic peptide bioregulators, including compounds targeting gonadal tissue (Khavinson et al., 2002, Bulletin of Experimental Biology and Medicine). Those studies do show some signal for gonadotropin and testosterone modulation in animal models and small human cohorts.

However, the specific compound Testigen (the synthetic dipeptide version) has not been evaluated in a randomized controlled trial published in a peer-reviewed journal indexed by PubMed or Cochrane. Animal testes-derived extracts have shown luteinizing hormone sensitization effects in rodent studies, but extrapolating that to a synthesized dipeptide in aging men is a significant leap. The mechanism, restoring hypothalamic-pituitary-gonadal axis signaling, is biologically plausible. Plausible is not the same as proven.

What did they get wrong (or right)?

The historical account is mostly accurate. Soviet bioregulator research was real, significant, and genuinely predates Western interest in peptide therapies by decades. The general lineage from tissue-derived cytomedins to synthetic analogs is consistent with Khavinson's published framework. Credit where it is due.

Where the video oversells: the creator presents Testigen's effects on testosterone, sperm count, libido, and ED as established facts, not as preliminary or investigational findings. Saying it "can also help with male infertility" and "increasing sperm count" without any human trial data to cite is misleading. Those are significant medical claims being made in a sales context.

The distinction between Testigen and exogenous testosterone is fair in principle. Bioregulators are not hormone replacement therapy. But framing it as something that simply "helps regulate and restore" natural function implies a safety and efficacy profile that has not been established through rigorous clinical testing in regulated markets. The U.S. FDA has not approved Testigen for any indication.

• Accurate: Cold War Soviet origins of bioregulator research
• Accurate: Conceptual distinction from exogenous testosterone
• Misleading: Presenting sperm count and infertility benefits as established
• Misleading: Framing the compound's safety and efficacy as settled

What should you actually know?

If you are considering Testigen or any bioregulator peptide for testosterone support, the regulatory and evidence situation matters as much as the mechanism. These compounds are not approved drugs in the United States. They are sold as research peptides or supplements, which means quality control, dosing standardization, and purity verification vary enormously between suppliers.

The hypothalamic-pituitary-gonadal axis is genuinely a target worth studying for age-related testosterone decline, and bioregulators represent an interesting pharmacological approach. But interesting is not a treatment plan. If your testosterone is declining and you are experiencing symptoms like fatigue, reduced libido, or fertility issues, those symptoms warrant evaluation by an endocrinologist or urologist, not a TikTok peptide vendor.

Compounds sold outside pharmaceutical-grade manufacturing can carry contamination risks, incorrect concentrations, and unknown long-term effects. Anyone presenting a peptide compound primarily in a sales context, with a link in their bio, has a financial interest in your decision. That is worth factoring in before you buy.